share_log

CytoMed Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-mDR Limited(11.59%)

CytoMed Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-mDR Limited(11.59%)

新细胞医学 | SC 13G:超过5%持股股东披露文件-mDR Limited(11.59%)
美股sec公告 ·  02/14 16:04
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息